0001209191-17-046966.txt : 20170801 0001209191-17-046966.hdr.sgml : 20170801 20170801182724 ACCESSION NUMBER: 0001209191-17-046966 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170525 FILED AS OF DATE: 20170801 DATE AS OF CHANGE: 20170801 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: FECZKO JOSEPH M CENTRAL INDEX KEY: 0001319874 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-35420 FILM NUMBER: 17997886 MAIL ADDRESS: STREET 1: PFIZER INC ATTN CORPORATE SECRETARY STREET 2: 235 EAST 42ND STREET CITY: NEW YORK STATE: NY ZIP: 10017 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ChemoCentryx, Inc. CENTRAL INDEX KEY: 0001340652 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943254365 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 850 MAUDE AVENUE CITY: MOUNTAIN VIEW STATE: CA ZIP: 94043 BUSINESS PHONE: 650-210-2900 MAIL ADDRESS: STREET 1: 850 MAUDE AVENUE CITY: MOUNTAIN VIEW STATE: CA ZIP: 94043 4/A 1 doc4a.xml FORM 4/A SUBMISSION X0306 4/A 2017-05-25 2017-05-30 0 0001340652 ChemoCentryx, Inc. CCXI 0001319874 FECZKO JOSEPH M C/O CHEMOCENTRYX, INC. 850 MAUDE AVENUE MOUNTAIN VIEW CA 94043 1 0 0 0 Common Stock 2017-05-25 4 A 0 12912 0.00 A 82096 D Restricted Stock Units 2017-05-25 4 D 0 12912 D Common Stock 12912 0 D The reporting person is amending the Form 4 originally filed to report restricted stock units awarded on May 25, 2017. The Form 4 should have reported the award as a restricted stock award. The restricted stock awarded on May 25, 2017, vests 100% on May 25, 2018, subject to the Reporting Person's continued service to the Company on such date. Shares will be delivered to the Reporting Person within thirty (30) days following the vesting date. Each restricted stock unit represents a contingent right to receive one share of CCXI common stock. /s/ Susan M. Kanaya, as Attorney-in-Fact 2017-08-01